We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Complete Response Meetings, QbD Included in Generic User Fee Draft
Complete Response Meetings, QbD Included in Generic User Fee Draft
December 9, 2011
The FDA has agreed to schedule 30-minute teleconferences with generic-drug makers upon request to discuss complete response letters under the proposed Generic Drug User Fee Act (GDUFA) goals letter.